Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
1.82M
-
Shares change
-
-25.7K
-
Total reported value, excl. options
-
$856M
-
Value change
-
-$12.1M
-
Number of buys
-
10
-
Number of sells
-
-8
-
Price
-
$471.56
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2023
23 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q4 2023.
Elevance Health, Inc. - Common Stock (ELV) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.82M shares
of 226M outstanding shares and own 0.8% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (21.2M shares), BlackRock Inc. (21M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.9M shares), STATE STREET CORP (10.4M shares), WELLINGTON MANAGEMENT GROUP LLP (5.91M shares), GEODE CAPITAL MANAGEMENT, LLC (4.52M shares), Sanders Capital, LLC (4.46M shares), FMR LLC (3.97M shares), AMERIPRISE FINANCIAL INC (3.71M shares), and Capital International Investors (3.37M shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.